Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nivolumab in squamous cell non-small cell lung cancer
NCT01642004Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Oct 2012
- Primary completion
- Nov 2014
- Modality
- Monoclonal Antibodies
- Countries
- 21
01
Overview
A Phase 3 trial of nivolumab in squamous cell carcinoma of the lung (SCCL), sponsored by Bristol Myers Squibb. Started Oct 2012; status: completed.
02
Drugs
03
Conditions
squamous cell carcinoma of the lung (SCCL)
Beyond the preview
Go deeper on NCT01642004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01642004.